Angiogenesis induced by urothelial cells (HCV-29) and their v-ras and v-raf transfectants

Cancer Letters

Volumn 131, Issue 2, 1998, Pages 157-161

  Przybyszewska, Małgorzata ^a   Miłoszewska, Joanna ^a   Janik, Przemysław ^a  

^a Maria Skodowska Curie Cancer C ^*  (Poland)

Author keywords

Angiogenesis; v raf; v ras; VEGF

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROTHELIUM;

ANIMALS; CELL LINE, TRANSFORMED; ENDOTHELIAL GROWTH FACTORS; GENES, RAS; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; ONCOGENE PROTEINS V-RAF; RETROVIRIDAE PROTEINS, ONCOGENIC; RNA, MESSENGER; TRANSFECTION; UROTHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0344015743     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00134-7     Document Type: Article

References (17)

1. Battegay E.J. Angiogenesis; mechanistic insights, neovascular diseases and therapeutic prospects. J. Mol. Med. 73:1995;333-346.
2. Berger D.P., Herbstritt W.A., Dengler W.A., Marme D., Mertelsmann R., Fiebig H.H. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Ann. Oncol. 6:1995;817-825.
3. Chomczyński P., Sacchi N. Single-step method RNA isolation by acid guanidinum thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Christensen B., Kieler J., Vilien M., Doug P., Wang C.J., Wolf H. A classification of human urothelial cells propagated in vitro. Anticancer Res. 4:1984;319-338.
5. Fidler I.J., Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
6. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst. 82:1990;4-6.
7. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31.
8. Grugel S., Finkenzeller G., Weindel K., Barleon B., Marme D. Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 43:1995;25915-25919.
9. Klagsbrun M., D'Amore P.A. Regulation of angiogenesis. Annu. Rev. Physiol. 53:1991;217-239.
10. Lowry C.H., Rosenbrough M.R., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
11. Pronk G.J., Bos L.J. The role of p21 ras in receptor tyrosine kinase signaling. Biochem. Biophys. Acta. 1198:1994;131-147.
12. Rak J., Mitsuhashi Y., Bayko L., Filmus J., Shirasawa S., Sasazuki T., Kerbel R.S. Mutant ras oncogenes upregulate VEGF/VPF expression; implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55:1995;4575-4580.
13. Senger D., Perruzzi C.A., Feder J., Dvorak K.F. A highly conserved permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res. 46:1986;5629-5632.
14. Sidky Y.A., Auerbach R. Lymphocyte-induced angiogenesis; a quantitative and sensitive assay of the graft - vs. - host reaction. J. Exp. Med. 141:1975;1084.
15. Skouv J., Ottesen S., Mark G., Autrup H. Malignant transformation of human bladder epithelial cells by DNA transfection with the v-raf oncogene. Mol. Carcinog. 2:1989;59-62.
16. Willumsen B.M., Christensen A., Hubbert N.L., Papageorge A.G., Lowy D.R. The p21 ras c-terminus is required for transformation and membrane association. Nature. 310:1984;583-586.
17. Willumsen B.M., Papageorge A.G., Kung F.J., Bekesi E., Robins T., Johnsen M., Vass W., Lowly D.R. Mutational analysis of a ras catalytic domain. Mol. Cell. Biol. 9:1986;2646-2654.